Safety and Efficacy Evaluation of TPN in Preterm Neonates in NICU of Cairo University Children Hospital

Status

UNKNOWN

Phases

Unknown

Study type

Observational

Source

ClinicalTrials.gov

Registry ID

NCT04723966

Enrollment

200

Registered

2021-01-26

Start date

2019-04-07

Completion date

2021-12-07

Last updated

2021-01-26

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

TPN in Preterm

Brief summary

The aim of this work is evaluation of electrolytes and minerals homeostasis and occurrence of complications among preterm babies receiving total parenteral nutrition, and admitted to the neonatal intensive care units of Cairo University Children hospitals.

Interventions

DIETARY_SUPPLEMENTTPN

Total parenteral nutrition

Study design

Observational model

OTHER

Time perspective

CROSS_SECTIONAL

Eligibility

Sex/Gender

ALL

Age

1 Days to 1 Months

Inclusion criteria

\- All preterm infants with gestational age \< 34 weeks, Receiving total parenteral nutrition. Normal serum magnesium.

Exclusion criteria

* Any full-term neonates Any patient with TORCH infection, chromosomal, metabolic disorders or surgical abnormality of the hepatobiliary system

Design outcomes

Primary

Measure	Time frame	Description
electrolyte and mineral disturbance associated with TPN in preterm receiving it	14 days	NA, K, MG, P, CA.

Secondary

Measure	Time frame	Description
prevalence of cholestasis and sepsis in preterm receiving TPN	14 days	clinical and laboratory examination

Countries

Egypt

Outcome results

None listed

Source: ClinicalTrials.gov · Data processed: Feb 4, 2026